Stock image Oral Antidiabetic
Prague,Czech Republic-August 10 2024: GLICLAZID MYLAN Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.28MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: GLICLAZID ACTAVIS Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.21MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: GLICLAZID MYLAN Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.23MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.08MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024: Xigduo Box Of Medication With Dapagliflozin Active Substance By AstraZeneca, Used For Treatment Of Type 2 Diabetes
Image, 2.41MB, 3024 × 4032 jpg
Prague,Czech Republic-August 7 2024: METFORMIN VIATRIS Box Of Medication With METFORMIN Active Substance By VIATRIS,used For Treatment Of Type 2 Diabetes
Image, 2.27MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA Box Of Medication With ALOGLIPTIN Active Substance By TAKEDA,used For Treatment Of Type 2 Diabetes
Image, 2.04MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: METFORMIN VIATRIS Box Of Medication With METFORMIN Active Substance By VIATRIS,used For Treatment Of Type 2 Diabetes
Image, 2.21MB, 3024 × 4032 jpg
Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.17MB, 3024 × 4032 jpg
Prague,Czech Republic-August 10 2024: GLICLAZID MYLAN Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.15MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes
Image, 2.45MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA Box Of Medication With ALOGLIPTIN Active Substance By TAKEDA,used For Treatment Of Type 2 Diabetes
Image, 2.01MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: GLICLAZID ACTAVIS Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.32MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: METFORMIN VIATRIS Box Of Medication With METFORMIN Active Substance By VIATRIS,used For Treatment Of Type 2 Diabetes
Image, 2.56MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: GLICLAZIDE MEDREG Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.11MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.18MB, 3024 × 4032 jpg
Prague,Czech Republic-August 10 2024: GLICLAZID ACTAVIS Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.29MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA Box Of Medication With ALOGLIPTIN Active Substance By TAKEDA,used For Treatment Of Type 2 Diabetes
Image, 2.07MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: GLICLAZIDE MEDREG Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 1.98MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: GLICLAZID MYLAN Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.25MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes
Image, 2.44MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: METFORMIN VIATRIS Box Of Medication With METFORMIN Active Substance By VIATRIS,used For Treatment Of Type 2 Diabetes
Image, 2.39MB, 4032 × 3024 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.3MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.72MB, 3024 × 4032 jpg
Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Structural Chemical, Dark Blue Background. Vector Illustration
Vector, 0.31MB, 6124 × 4082 eps
Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Molecular Model. 3D Rendering. Illustration
Image, 6.03MB, 9000 × 4460 jpg
Glibenclamide, Glyburide Molecule. Sulfonylurea Used In The Treatment Of Non Insulin Dependent Diabetes Mellitus. Structural Chemical Formula, Dark Blue Background. Vector Illustration
Vector, 0.31MB, 6847 × 3651 eps
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.25MB, 4032 × 3024 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.39MB, 3024 × 4032 jpg
Prague, Czech Republic - July 9 2024: SITAGLIPTIN METFORMIN TEVA Box Of Tablets With SITAGLIPTIN And METFORMIN Active Substances By TEVA, Used For Treatment Of Type 2 Diabetes.
Image, 2.3MB, 4032 × 3024 jpg
Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Skeletal Chemical Formula. Paper Packaging For Drugs. Vector Illustration
Vector, 0.31MB, 6547 × 3819 eps
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.37MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.24MB, 3024 × 4032 jpg
Glibenclamide, Glyburide Molecule. Sulfonylurea Used In The Treatment Of Non Insulin Dependent Diabetes Mellitus. Structural Chemical Formula, Molecule Model. Vector Illustration
Vector, 0.43MB, 5590 × 4472 eps
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.28MB, 4032 × 3024 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.28MB, 4032 × 3024 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.24MB, 3024 × 4032 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.42MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.12MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.2MB, 4032 × 3024 jpg
Prague, Czech Republic - July 9 2024: SITAGLIPTIN METFORMIN TEVA Box Of Tablets With SITAGLIPTIN And METFORMIN Active Substances By TEVA, Used For Treatment Of Type 2 Diabetes.
Image, 2.32MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.33MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.28MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.23MB, 4032 × 3024 jpg
Page 1 >> Next